Home » ADDEX-ORTHO-McNEIL TIE-UP TO DEVELOP TREATMENTS FOR ANXIETY, DEPRESSION & AD
ADDEX-ORTHO-McNEIL TIE-UP TO DEVELOP TREATMENTS FOR ANXIETY, DEPRESSION & AD
Addex Pharmaceuticals has entered an exclusive worldwide research collaboration and license agreement with Ortho-McNeil Pharmaceutical, a Johnson & Johnson company, to discover, develop and commercialize novel compounds modulating allosterically G-Protein Coupled Receptors for the treatment of anxiety, depression, schizophrenia and Alzheimer's disease.
PharmaBiz (http://www.pharmabiz.com/article/detnews.asp?articleid=25738§ionid=)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May